Sign in

CIK 0001339970 · Non-accelerated filer<br>Smaller reporting company

aTYR PHARMA INC

Sign in to watch
Ticker
ATYR
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
203435077
Phone
8587318389
Business address
10240 SORRENTO VALLEY ROAD, SUITE 300, SAN DIEGO, CA, 92121
  1. 8-K Event Delisting notice
  2. SC 13G/A Stake Amended Statement of Ownership
  3. 4 Open-market buy Director bought 245,000 shares at an average $0.42 ($103,247)
  4. 4 Open-market buy Director bought 147,225 shares at $0.54 ($79,796)
  5. 10-Q Report Quarterly Report
  6. 8-K Event Results of operations
  7. 8-K Event Executive or director change · Regulation FD disclosure
  8. 4 Open-market buy Chief Financial Officer bought 64,000 shares at an average $0.83 ($52,855)
  9. 4 Open-market buy Chief Financial Officer bought 26,000 shares at $0.73 ($19,055)
  10. SC 13D Stake Beneficial Ownership Report
  11. 4 Open-market buy Director bought 42,749 shares at an average $0.74 ($31,461)
  12. 4 Open-market buy Director bought 164,411 shares at an average $0.74 ($121,573)
  13. 8-K Event Executive or director change
  14. 10-Q Report Quarterly Report
  15. 8-K Event Results of operations · Delisting notice
  16. 4 Derivatives Options or other derivatives
  17. 3 Insider Initial Statement of Ownership
  18. 8-K Event Material agreement · Executive or director change
  19. 8-K Event Regulation FD disclosure · Other events
  20. 8-K Event Regulation FD disclosure · Other events

Page 22 of 38 · 755 filings